Glomerulopathies with Fibrillary Deposits

Author:

Dzekova-Vidimliski Pavlina12,Karanfilovski Vlatko12,Nikolov Igor G12,Rambabova-Bushljetik Irena12,Ristovska Vesna12,Petrushevska Gordana3,Selim Gjulsen12

Affiliation:

1. 1 University Hospital of Nephrology , Skopje , RN Macedonia

2. 2 Faculty of Medicine , Ss. Cyril and Methodius University in Skopje , Skopje , RN Macedonia

3. 3 Institute for Pathology, Faculty of Medicine , Ss. Cyril and Methodius University in Skopje , Skopje , RN Macedonia

Abstract

Abstract The glomerulopathies associated with the deposition of extracellular fibrils in the glomeruli are subdivided into Congo red positive (amyloidosis) and Congo red negative (non-amyloidotic glomerulopathies) based on Congo red staining. The non-amyloidotic glomerulopathies are divided into immunoglobulin-derived and non-immunoglobulin-derived glomerulopathies. The immunoglobulin-derived glomerulopathies: fibrillary glomerulopathy (FGn) and immunotactoid glomerulopathy (ITG) are rare glomerulopathies. The diagnosis of fibrillary-immunotactoid glomerulopathy depends on electron microscopy, which shows the presence of microfibrils in the glomeruli. The microfibrils in FGn are randomly arranged with diameters less than 30 nm. The microfibrils in ITG are larger than 30 nm with a visible lumen (microtubules), focally arranged in parallel bundles. Patients with fibrillary-immunotactoid glomerulopathy present with proteinuria (usually in the nephrotic range), microscopic hematuria, arterial hypertension, and chronic kidney disease that progresses to kidney failure over months to years. Currently, there are no guidelines for the treatment of fibrillary-immunotactoid glomerulopathy, although immunotactoid glomerulopathy could be associated with underlying hematologic disorders with the need for clone-directed therapy.

Publisher

Walter de Gruyter GmbH

Reference22 articles.

1. Brady HR. Fibrillary glomerulopathy. Kidney Int. 1998 May; 53(5):1421-1429.

2. Nasr SH, Vrana JA, Dasari S, et al. DNAJB9 Is a Specific Immunohistochemical Marker for Fibrillary Glomerulonephritis. Kidney Int Rep. 2017 Aug 8;3(1):56-64.

3. Nachman H.P, Jennette J.C, Falk J.R. Primary Glomerular Diseases. In: Brenner and Rector’s The Kidney, 8th ed.W B Saunders Co. 2007. pp 1032-1034.

4. DynaMed. Glomerular Diseases Due to Nonamyloid Organized Deposits. EBSCO Information Services. Accessed September 11, 2022. www.dynamed.com/condition/glomerular-diseases-due-to-nonamyloid-organized-deposits.

5. Yazaki M, Ikeda S. Characterization of amyloidosis. Brain Nerve. 2014 Jul;66(7):723-730.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3